 |
Entelos applies predictive biosimulation and a unique in silico approach to solve real problems for
pharmaceutical companies today. Through collaborative research, Entelos has already helped its
customers to:
- Screen genes of unknown function for their potential as drug targets
- Analyze gene expression data and determine the impact that specific genes would actually have on the disease state, taking into account the effects of regulatory networks
- Leverage knowledge from failed compounds to optimize the next generation
- Prioritize drug targets based on the ultimate criteria: their clinical impact on patients
- Understand why a treatment that worked in animals would fail in humans, prior to clinical trials
- Understand the biological mechanism behind a clinical trial result
- Evaluate a drug compared to competing drugs on the market
- Understand that a commonly held hypothesis about disease function, and the basis for research
strategies industry-wide, was incorrect and why
|
 |
